Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93.1M
-
Number of holders
-
250
-
Total 13F shares, excl. options
-
92.6M
-
Shares change
-
-1.55M
-
Total reported value, excl. options
-
$3.28B
-
Value change
-
-$49.8M
-
Put/Call ratio
-
1.04
-
Number of buys
-
121
-
Number of sells
-
-138
-
Price
-
$35.40
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q1 2015
320 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q1 2015.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 250 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92.6M shares
of 93.1M outstanding shares and own 99.46% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (9.93M shares), Capital Research Global Investors (8.94M shares), Capital World Investors (8.94M shares), SCOPIA CAPITAL MANAGEMENT LP (5.81M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (5.41M shares), VANGUARD GROUP INC (4.75M shares), ROYCE & ASSOCIATES LLC (3.4M shares), FIRST TRUST ADVISORS LP (3.33M shares), BlackRock Institutional Trust Company, N.A. (1.87M shares), and Sterling Capital Management LLC (1.68M shares).
This table shows the top 250 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.